IPO Timeline
Broker Results (T-2)
2020-12-23
Some brokers release in afternoon
Grey Market (T-1)
2020-12-24
Afternoon
HKEX Allotment (T-1)
2020-12-24
Evening
Registrar Allotment (T-1)
2020-12-24
Evening
Listing Day (T)
2020-12-28
First day of trading
Company Overview
| Stock Name | 瑞麗醫美國際控股有限公司 |
|---|---|
| Stock Code | 02135 |
| Company Full Name | 瑞麗醫美國際控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事提供醫療美容服務及諮詢服務。 |
| Listing Date | 2020-12-28 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市下城區中山北路290號民航大廈3–5樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.raily.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 0.40 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 21.9% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 68,500,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 0.435 |
|---|---|
| First Day Open | HK$ 0.475 |
| First Day Change | 8.75% |
| First Day Volume | 819968000.0 |
| First Day Turnover | 386834000.0 |
Use of Proceeds
| Use of Proceeds | 1、約28.0%，或19.7百萬港元，將用作翻新所有現有醫療美容機構并擴張杭州瑞麗、瑞麗天鴿及蕪湖瑞麗，以提升能力、更新品牌形象及擴大市場份額； 2、約28.0%，或19.7百萬港元，將用作為上海市新建醫療美容機構的資本支出及初始營運成本提供資金； 3、約15.0%，或10.6百萬港元，將用作中國浙江省醫療美容機構的潛在戰略收購； 4、約11.0%，或7.8百萬港元，將用作購買醫療美容服務設備及醫療消耗品，以完善若干醫療美容診療，擴大醫療美容服務范圍； 5、約8.0%，或5.6百萬港元將用于積極推廣我們的品牌； 6、約10%，或7.0百萬港元，將用作一般營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
INNOVAX CAPITAL LIMITED CE BDT371
Overall Coordinators (2)
INNOVAX SECURITIES LIMITED CE BHV052
千里硕证券有限公司
Joint Bookrunners (5)
INNOVAX SECURITIES LIMITED CE BHV052
千里硕证券有限公司
交银国际证券有限公司 CE APJ121
安信国际证券(香港)有限公司
First Fidelity Capital (International) Limited CE AMS441
Joint Lead Managers (9)
INNOVAX SECURITIES LIMITED CE BHV052
千里硕证券有限公司
交银国际证券有限公司 CE APJ121
安信国际证券(香港)有限公司
First Fidelity Capital (International) Limited CE AMS441
Kirin Securities Limited CE BJB225
KINGKEY SECURITIES GROUP LIMITED CE AXG710
Realord Asia Pacific Securities Limited CE AVJ441
太阳国际证券有限公司
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 昊海生物科技控股有限公司 | 20,000,000 HKD | — | 14.60% | — | 6 months | 2021-06-28 |
| 2 | 途益香港有限公司 | 10,000,000 HKD | — | 7.30% | — | 6 months | 2021-06-28 |
Directors & Management
| Chairman | 傅海曙 |
|---|---|
| Company Secretary | 陳愛發 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 傅海曙(53.10%);美天下責任(香港)有限公司(6.18%);上海東嫿健康管理合伙企業(有限合伙)(5.37%) |
|---|
IPO Timeline
